Bausch Health Companies Inc
NYSE:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
NYSE:BHC
Watchlist
Price: 7.45 USD -0.67%
Market Cap: 2.7B USD

Wall Street
Price Targets

BHC Price Targets Summary
Bausch Health Companies Inc

Wall Street analysts forecast BHC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BHC is 7.35 USD with a low forecast of 7.28 USD and a high forecast of 7.57 USD.

Lowest
Price Target
7.28 USD
2% Downside
Average
Price Target
7.35 USD
1% Downside
Highest
Price Target
7.57 USD
2% Upside
Bausch Health Companies Inc Competitors:
Price Targets
LUPIN
Lupin Ltd
6% Upside
TARS
Tarsus Pharmaceuticals Inc
20% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
36% Upside
VENUSREM
Venus Remedies Ltd
57% Downside
600285
Henan Lingrui Pharmaceutical Co Ltd
38% Upside
ORCHPHARMA
Orchid Pharma Ltd
32% Upside
4502
Takeda Pharmaceutical Co Ltd
0% Upside

Revenue
Forecast

Revenue Estimate
Bausch Health Companies Inc

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 11%. The projected CAGR for the next 4 years is 0%.

11%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bausch Health Companies Inc

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 10%. The projected CAGR for the next 4 years is 11%.

10%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-57%
Average Miss

Net Income
Forecast

Net Income Estimate
Bausch Health Companies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BHC's stock price target?
Price Target
7.35 USD

According to Wall Street analysts, the average 1-year price target for BHC is 7.35 USD with a low forecast of 7.28 USD and a high forecast of 7.57 USD.

What is Bausch Health Companies Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 11%. The projected CAGR for the next 4 years is 0%.

What is Bausch Health Companies Inc's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 10%. The projected CAGR for the next 4 years is 11%.

Back to Top